Continuous subcutaneous insulin infusion in diabetes mellitus type 1 and 2: Lower HbA1c-values and a high level of patient satisfaction;Continue subcutane insuline-infusie bij diabetes mellitus type 1 en 2: Lagere HbA1c-waarden en grote patiëntentevredenheid

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 41, 2003, Pages 2021-2025

  De Borst, J M ^a   Berghout, A ^a  

^a Medisch Centrum Rijnmond Zuid   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; DOSE RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; PATIENT SATISFACTION; RETROSPECTIVE STUDIES;

EID: 0142056236     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Pickup JC, Keen H, Parsons JA, Alberti KGMM. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J 1978;1:204-7.
2. Mecklenburg RS, Benson EA, Benson jr JW, Fredlund PN, Guinn T, Metz RJ, et al. Acute complications associated with insulin pump therapy. Report of experience with 161 patients. JAMA 1984;252: 3265-9.
3. Helve E, Laatikainen L, Merenmies L, Koivisto VA. Continuous insulin infusion therapy and retinopathy in patients with type 1 diabetes. Acta Endocrinol (Copenh) 1987;115:313-9.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
5. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986;2(8519):1300-4.
6. Jakobsen J, Christiansen JS, Kristoffersen I, Christensen CK, Hermansen K, Schmitz A, et al. Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes 1988;37:452-5.
7. Bibergeil H, Huttl I, Felsing W, Felsing U, Seidlein I, Herfurth S, et al. 36 Months continuous subcutaneous insulin infusion (CSII) in insulin dependent diabetes (IDDM) - influence on early stages of retinopathy, nephropathy and neuropathy - psychological analysis. Exp Clin Endocrinol 1987;90:51-61.
8. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 2001;161:2293-300.
9. Maniatis AK, Klingensmith GJ, Slover RH, Mowry CJ, Chase HP. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001; 107:351-6.
10. Jennings AM, Lewis KS, Murdoch S, Talbot JF, Bradley C, Ward JD. Randomized trial comparing continuous subcutaneous insulin infusion and conventional insulin therapy in type II diabetic patients poorly controlled with sulfonylureas. Diabetes Care 1991;14:738-44.
11. Pickup JC, Keen H. Continuous subcutaneous insulin infusion in type 1 diabetes. BMJ 2001;322:1262-3.
12. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000:321:405-12.
13. Polonsky KS, Given BD, Cauter E van. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 1988;81:442-8.
14. Catargi B, Breilh D, Gin H, Rigalleau V, Saux MC, Roger P, et al. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps. Diabetes Metab 2001;27:323-7.
15. Pickup JC, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25:593-8.
16. Pickup JC, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2002;324:705-8.
17. DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care 2002;25:2074-80.